BR9810917A - Polipeptìdeo isolado, proteìna de fusão, vetor de expressão, célula cultivada, processo para produzir um polipeptìdeo, composição farmacêutica, anticorpo, proteìna de ligação, polinucleotìdeo isolado, e, sonda de oligonucleotìdeo ou iniciador - Google Patents

Polipeptìdeo isolado, proteìna de fusão, vetor de expressão, célula cultivada, processo para produzir um polipeptìdeo, composição farmacêutica, anticorpo, proteìna de ligação, polinucleotìdeo isolado, e, sonda de oligonucleotìdeo ou iniciador

Info

Publication number
BR9810917A
BR9810917A BR9810917-0A BR9810917A BR9810917A BR 9810917 A BR9810917 A BR 9810917A BR 9810917 A BR9810917 A BR 9810917A BR 9810917 A BR9810917 A BR 9810917A
Authority
BR
Brazil
Prior art keywords
polypeptide
isolated
antibody
pharmaceutical composition
produce
Prior art date
Application number
BR9810917-0A
Other languages
English (en)
Portuguese (pt)
Inventor
Paul O Sheppard
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Publication of BR9810917A publication Critical patent/BR9810917A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
BR9810917-0A 1997-07-18 1998-07-17 Polipeptìdeo isolado, proteìna de fusão, vetor de expressão, célula cultivada, processo para produzir um polipeptìdeo, composição farmacêutica, anticorpo, proteìna de ligação, polinucleotìdeo isolado, e, sonda de oligonucleotìdeo ou iniciador BR9810917A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5315497P 1997-07-18 1997-07-18
PCT/US1998/014864 WO1999004000A1 (en) 1997-07-18 1998-07-17 Adipocyte-specific protein homologs

Publications (1)

Publication Number Publication Date
BR9810917A true BR9810917A (pt) 2000-08-15

Family

ID=21982287

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9810917-0A BR9810917A (pt) 1997-07-18 1998-07-17 Polipeptìdeo isolado, proteìna de fusão, vetor de expressão, célula cultivada, processo para produzir um polipeptìdeo, composição farmacêutica, anticorpo, proteìna de ligação, polinucleotìdeo isolado, e, sonda de oligonucleotìdeo ou iniciador

Country Status (18)

Country Link
US (2) US6265544B1 (enExample)
EP (1) EP1002075B1 (enExample)
JP (1) JP3762220B2 (enExample)
KR (1) KR100385868B1 (enExample)
CN (1) CN1201003C (enExample)
AT (1) ATE327328T1 (enExample)
AU (1) AU743745B2 (enExample)
BR (1) BR9810917A (enExample)
CA (1) CA2296530A1 (enExample)
DE (1) DE69834643T2 (enExample)
DK (1) DK1002075T3 (enExample)
ES (1) ES2264207T3 (enExample)
HU (1) HUP0003762A3 (enExample)
IL (1) IL134011A0 (enExample)
NO (1) NO20000215L (enExample)
PL (1) PL338139A1 (enExample)
RU (1) RU2218402C2 (enExample)
WO (1) WO1999004000A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020137890A1 (en) * 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US6566499B1 (en) * 1997-07-18 2003-05-20 Zymogenetics, Inc. Adipocyte-specific protein homologs
US6265544B1 (en) * 1997-07-18 2001-07-24 Zymogenetics, Inc. Adipocyte-specific protein homologs
FR2767135B1 (fr) 1997-08-06 2002-07-12 Genset Sa Recepteur complexe lsr, activite, clonage, et application au diagnostic, a la prevention et/ou au traitement de d'obesite et des risques ou complications associes
US20030129691A1 (en) * 1998-02-09 2003-07-10 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US7300774B1 (en) 1999-12-09 2007-11-27 The Regents Of The University Of California Multimeric fusion proteins of the TNF superfamily ligands
US6544946B1 (en) * 1999-02-19 2003-04-08 Zymogenetics, Inc. Inhibitors for use in hemostasis and immune function
AU772103B2 (en) 1999-02-19 2004-04-08 Zymogenetics Inc. Inhibitors for use in hemostasis and immune function
US20040014650A1 (en) * 2002-07-17 2004-01-22 Sheppard Paul D Methods for enhancing wound repair
AU5037100A (en) * 1999-05-27 2000-12-18 Zymogenetics Inc. Adipocyte complement related protein homolog zacrp6
JP2003501027A (ja) * 1999-05-27 2003-01-14 ザイモジェネティクス，インコーポレイティド 脂肪細胞補体関連タンパク質同族体ｚａｃｒｐ５
US20050042719A1 (en) * 1999-05-27 2005-02-24 Zymogenetics, Inc. Adipocyte complement related protein homolog zacrp5
DE60043367D1 (de) * 1999-06-15 2009-12-31 Genentech Inc Sekretierte und Transmembran-Polypeptide sowie Nukleinsäuren zu deren Kodierung
JP2003504022A (ja) * 1999-07-01 2003-02-04 ザイモジェネティクス，インコーポレイティド 分泌されるタンパク質ｚａｃｒｐ４
DE19963859A1 (de) * 1999-12-30 2001-07-12 Apotech Res & Dev Ltd Bi- oder Oligomer eines Di-, Tri-, Quattro- oder Pentamers von rekombinanten Fusionsproteinen
AU2001297656A1 (en) * 2000-11-29 2002-09-19 Zymogenetics, Inc. Adipocyte complement related protein zacrp11
IL156864A0 (en) 2001-01-16 2004-02-08 Genset Sa Polynucleotides and polypeptides and their use in metabolic disorders
WO2002055694A2 (en) * 2001-01-16 2002-07-18 Genset Sa Discriminative nucleic acid analysis using clone sequence signatures
US20030220253A1 (en) * 2002-03-08 2003-11-27 Lasser Gerald W. Inhibitors for use in hemostasis
JP2008507591A (ja) * 2004-05-21 2008-03-13 ゼンコー・インコーポレイテッド 免疫原性が改変されたＣ１ｑファミリーメンバータンパク質

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0679716A4 (en) * 1993-11-12 1999-06-09 Kenichi Matsubara GENE SIGNATURE.
US5869330A (en) * 1995-06-05 1999-02-09 Whitehead Institute For Biomedical Research DNA encoding a novel serum protein produced exclusively in adipocytes
US6265544B1 (en) * 1997-07-18 2001-07-24 Zymogenetics, Inc. Adipocyte-specific protein homologs
NZ522634A (en) * 1997-12-03 2004-02-27 Genentech Inc PRO243 encoding a polypeptide with homology to chordin and antibodies and vectors

Also Published As

Publication number Publication date
AU743745B2 (en) 2002-02-07
HUP0003762A2 (hu) 2001-08-28
NO20000215L (no) 2000-03-17
KR100385868B1 (ko) 2003-06-02
DE69834643D1 (de) 2006-06-29
AU8411398A (en) 1999-02-10
CN1201003C (zh) 2005-05-11
CN1272883A (zh) 2000-11-08
RU2218402C2 (ru) 2003-12-10
CA2296530A1 (en) 1999-01-28
ES2264207T3 (es) 2006-12-16
JP3762220B2 (ja) 2006-04-05
PL338139A1 (en) 2000-09-25
KR20010021973A (ko) 2001-03-15
US6518403B2 (en) 2003-02-11
DE69834643T2 (de) 2007-05-10
WO1999004000A1 (en) 1999-01-28
JP2001510045A (ja) 2001-07-31
DK1002075T3 (da) 2006-09-18
IL134011A0 (en) 2001-04-30
ATE327328T1 (de) 2006-06-15
US6265544B1 (en) 2001-07-24
US20020156243A1 (en) 2002-10-24
EP1002075B1 (en) 2006-05-24
EP1002075A1 (en) 2000-05-24
HUP0003762A3 (en) 2005-11-28
NO20000215D0 (no) 2000-01-17

Similar Documents

Publication Publication Date Title
Feramisco Microinjection of fluorescently labeled α-actinin into living fibroblasts
Beyer et al. Two lactose binding lectins from chicken tissues. Purified lectin from intestine is different from those in liver and muscle.
Langeveld et al. Structural heterogeneity of the noncollagenous domain of basement membrane collagen.
Savage et al. Modulation of platelet function through adhesion receptors. A dual role for glycoprotein IIb-IIIa (integrin alpha IIb beta 3) mediated by fibrinogen and glycoprotein Ib-von Willebrand factor.
NO20000934L (no) Adipocyttspesifikke proteinhomologer
Murphy et al. Clathrin assembly protein AP-3: The identity of the 155K protein, AP 180, and NP185 and demonstration of a clathrin binding domain
Hisanaga et al. Dephosphorylation-induced interactions of neurofilaments with microtubules.
Schwyter et al. Subtilisin cleavage of actin inhibits in vitro sliding movement of actin filaments over myosin.
Kuznetsov et al. 18 kDa microtubule‐associated protein: identification as a new light chain (LC‐3) of microtubule‐associated protein 1 (MAP‐1)
KR950032279A (ko) 인체의 프로그램된 세포 사멸과 관련 있는 펩티드 및 이를 암호하는 디엔에이(dna)
BR0008772A (pt) Polipeptìdeo isolado, proteìna de fusão, molécula de polinucleotìdeo isolado, vetor de expressão, célula cultivada, anticorpo, processos para produzir uma proteìna e um anticorpo para um polipeptìdeo, para estimular uma resposta imunológica em um mamìfero, para expandir células hematopoiéticas e progenitores de células hematopoiéticas, para reduzir a proliferação de células b ou t neoplásicas e para detectar a presença de rna de ligando zalfa11 e de ligando zalfal11 em uma amostra biológica
ATE213837T1 (de) Polypeptid-dendrimer komplexe
Van Eldik et al. Interaction of calmodulin and other calcium-modulated proteins with mammalian and arthropod junctional membrane proteins
DK1002075T3 (da) Adipocyt-specifikke proteinhomologer
DE69536123D1 (de) Fusionsprotein dass bpTK7 enthält
Nakai et al. Transformation of BALB/3T3 cells by simian virus 40 causes a decreased synthesis of a collagen-binding heat-shock protein (hsp47).
Tedeschi et al. Purification and primary structure of a new bovine spermadhesin
BR9509172A (pt) Proteina de via de complemento nativa sequéncia de dna construção de dna conjugado uso de uma proteína processo para reduzir proteina de via de complemento em um mamifero e formulação farmacéutica
Isaacs et al. Association of titin and myosin heavy chain in developing skeletal muscle.
Walter et al. The Oligomerization of the Coiled Coil‐domain of Occluddin Is Redox Sensitive
ATE372384T1 (de) Protein-tyrosin-phosphatase ptp-s31
BR9913942A (pt) Polinucleotìdeo e polipeptìdeo isolado, vetor de expressão, célula cultivada, constructo de dna codificador de uma proteìna de fusão, processos de produção de uma proteìna, de fusão de um polipeptìdeo e de um anticorpo para o polipeptìdeo e de detecção, em uma amostra de teste, da presença de um modulador da atividade da proteìna zalpha11 e de um ligante de receptor zalpha11 dentro de uma amostra de teste, e, anticorpo
Schwanbeck et al. Cdc2 and Mitogen-activated Protein Kinases Modulate DNA Binding Properties of the Putative Transcriptional RegulatorChironomus High Mobility Group Protein I
Kumagai et al. Disulfide‐bonding between Drosophila laminin β and γ chains is essential for α chain to form αβγ trimer
Aizawa et al. Limited chymotryptic digestion of bovine adrenal 190,000-Mr microtubule-associated protein and preparation of a 27,000-Mr fragment which stimulates microtubule assembly.

Legal Events

Date Code Title Description
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: DE ACORDO COM O ART 36 DA LPI (LEI 9.279/96) 2O, O PEDIDO VOLTA A EXAME SENDO CONSIDERADO NAO PATENTEAVEL PELAS RAZOES EXPOSTAS NO PARECER TECNICO ANTERIOR.